Preventive IVIG Therapy for Congenital Heart Block

Clinical trial NCT00460928 · COMPLETED

Trial details

NCT number: NCT00460928
Sponsor: NYU Langone Health
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Congenital Heart Block Neonatal Lupus Autoantibody-associated Heart Block

Start date: 2007-04-01
Primary completion: 2009-06-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.